---

---

symbols : Nvs   

save search

---

Gene therapy market size to grow by USD 4,613.9 million from 2022 to 2027 | North America is estimated to contribute 39% to the growth - Technavio
Published: 2023-12-12 (Crawled : 08:00) - prnewswire.com
ALPMF | News | $9.75 43.47% 200 |

Health Technology

| -18.41% | O: -0.42% H: 0.0% C: 0.0%
NVSEF | News | $95.11 6.88% 490 |

Health Technology

| -0.93% | O: 1.56% H: 0.51% C: 0.51%
ALPMY | News | $9.53 -1.11% 690K |

Manufacturing

| -19.78% | O: -5.13% H: 5.41% C: 3.46%
NVS | News | $97.28 2.27% 0.31% 3.7M |

Health Technology

| -2.58% | O: 0.45% H: 0.75% C: 0.46%
ORTX | $16.7 0.0% 370K |

Health Technology

| 2.15% | O: 0.18% H: 0.43% C: 0.25%
GBIO | News | $3.27 16.37% 14.07% 210K |

Health Technology

| 57.87% | O: 5.62% H: 3.72% C: -4.26%
BIIB | $193.18 -0.48% -0.48% 1.4M |

Health Technology

| -21.13% | O: 0.59% H: 1.35% C: 0.6%
AMGN | News | $273.69 0.66% 0.65% 2.5M |

Health Technology

| -0.08% | O: 1.83% H: 0.04% C: -1.13%
ADAP | $1.12 10.89% 9.82% 1.1M |

Health Technology

| 101.0% | O: -0.46% H: 5.56% C: -1.12%
ABEO | News | $3.395 -53.87% -116.79% 5.5M |

Health Technology

| 59.65% | O: 0.65% H: 2.59% C: 0.86%
america therapy growth market

---

Radiopharmaceuticals market size to grow by USD 4.37 billion from 2021 to 2026 | Actinium Pharmaceuticals Inc., Bayer AG, Bracco Spa, BWX Technologies Inc. and more among the key companies in the market - Technavio
Published: 2023-12-12 (Crawled : 06:00) - prnewswire.com
NVSEF | News | $95.11 6.88% 490 |

Health Technology

| -0.93% | O: 1.56% H: 0.51% C: 0.51%
NVS | News | $97.28 2.27% 0.31% 3.7M |

Health Technology

| -2.58% | O: 0.45% H: 0.75% C: 0.46%
FUSN | $21.42 0.47% 0.47% 1.9M |

Health Technology

| 328.97% | O: 2.01% H: 4.73% C: 3.55%
companies pharmaceuticals market

---

Precision Medicine Market size to grow by USD 54.07 billion from 2022 to 2027, The growing prevalence of chronic diseases to boost market growth - Technavio
Published: 2023-12-12 (Crawled : 05:00) - prnewswire.com
AZNCF | News | $138.73 -4.19% 3.7K |

Health Technology

| 10.81% | O: 5.03% H: 0.0% C: -3.82%
NVSEF | News | $95.11 6.88% 490 |

Health Technology

| -0.93% | O: 1.56% H: 0.51% C: 0.51%
TMO | News | $574.59 4.78% -1.12% 2.5M |

Health Technology

| 11.61% | O: 0.86% H: 0.0% C: 0.0%
NVS | News | $97.28 2.27% 0.31% 3.7M |

Health Technology

| -2.58% | O: 0.45% H: 0.75% C: 0.46%
ABBV | News | $169.54 0.98% -0.91% 4.1M |

Health Technology

| 11.3% | O: 0.59% H: 1.23% C: 1.0%
SNY | News | $47.69 1.15% 1.13% 1.7M |

Health Technology

| -1.97% | O: 0.43% H: 0.0% C: 0.0%
AZN | News | $70.85 1.03% 1.02% 5.6M |

Health Technology

| 10.44% | O: 1.54% H: 0.06% C: -0.78%
AMGN | News | $273.69 0.66% 0.65% 2.5M |

Health Technology

| -0.08% | O: 1.83% H: 0.04% C: -1.13%
growing growth market

---

US Kidney Cancer Therapeutics and Diagnostics Market to 2028, Featuring Profiles of Amgen, Hoffman-La Roche, Bayer, Pfizer, Bristol Myers Squibb and Novartis
Published: 2023-12-12 (Crawled : 01:00) - prnewswire.com
NVSEF | News | $95.11 6.88% 490 |

Health Technology

| -0.93% | O: 1.56% H: 0.51% C: 0.51%
NVS | News | $97.28 2.27% 0.31% 3.7M |

Health Technology

| -2.58% | O: 0.45% H: 0.75% C: 0.46%
AMGN | News | $273.69 0.66% 0.65% 2.5M |

Health Technology

| -0.08% | O: 1.83% H: 0.04% C: -1.13%
kidney cancer novartis diagnostics therapeutics market

---

Low-Density Lipoprotein Test Global Market Report 2023, By Product Type (LDL-C; LDL-P; LDL-B) , By Component, By Disease Type, By Distribution Channel and By End User
Published: 2023-12-11 (Crawled : 17:00) - prnewswire.com
QGEN | $41.89 1.63% 0.0% 900K |

Health Technology

| -1.42% | O: -0.02% H: 0.9% C: 0.77%
NVS | News | $97.28 2.27% 0.31% 3.7M |

Health Technology

| -1.59% | O: 0.75% H: 0.55% C: 0.27%
DHR | $253.11 7.21% 0.0% 6.8M |

Health Technology

| 8.55% | O: 0.27% H: 1.66% C: 1.5%
ABT | News | $107.59 0.49% -0.09% 3.8M |

Health Technology

| 2.7% | O: 0.09% H: 0.0% C: 0.0%
QGEN | $41.89 1.63% 0.0% 900K |

Health Technology

| -1.42% | O: -0.02% H: 0.9% C: 0.77%
disease report test distribution global market

---

Erasca Granted FDA Fast Track Designation for Pan-RAF Inhibitor Naporafenib in Patients with Advanced NRAS-Mutated Melanoma
Published: 2023-12-11 (Crawled : 13:00) - globenewswire.com
ERAS | $1.93 4.32% 4.15% 440K |

| -1.07% | O: 1.07% H: 0.0% C: -2.65%
NVS | News | $97.28 2.27% 0.31% 3.7M |

Health Technology

| -1.59% | O: 0.75% H: 0.55% C: 0.27%
fda melanoma granted designation advanced

---

Novartis investigational iptacopan Phase III study demonstrates clinically meaningful and statistically significant proteinuria reduction in patients with C3 glomerulopathy (C3G)
Published: 2023-12-11 (Crawled : 07:00) - globenewswire.com
NVS | News | $97.28 2.27% 0.31% 3.7M |

Health Technology

| -1.59% | O: 0.75% H: 0.55% C: 0.27%
novartis study

---

Novartis presents new 48-week results from Phase III APPLY-PNH trial showing sustained efficacy and long-term safety of Fabhalta® (iptacopan) in adults with paroxysmal nocturnal hemoglobinuria (PNH)
Published: 2023-12-11 (Crawled : 01:00) - globenewswire.com
NVS | News | $97.28 2.27% 0.31% 3.7M |

Health Technology

| -1.59% | O: 0.75% H: 0.55% C: 0.27%
fabhalta novartis trial results

---

S&P Dow Jones Indices Announces Dow Jones Sustainability Indices 2023 Review Results
Published: 2023-12-08 (Crawled : 23:00) - prnewswire.com
TCEHY | News | $41.02 0.04% 3.9M |

Information

| Email alert Add to watchlist
AZN | News | $70.85 1.03% 1.02% 5.6M |

Health Technology

| Email alert Add to watchlist
TCTZF | News | $40.3 2.11% 5.8K |

Technology Services

| Email alert Add to watchlist
NVSEF | News | $95.11 6.88% 490 |

Health Technology

| Email alert Add to watchlist
NVS | News | $97.28 2.27% 0.31% 3.7M |

Health Technology

| Email alert Add to watchlist
AZNCF | News | $138.73 -4.19% 3.7K |

Health Technology

| Email alert Add to watchlist
SPGI | News | $413.26 -0.88% 0.0% 2.2M |

Commercial Services

| Email alert Add to watchlist
DNOW | $15.15 4.27% 0.0% 790K |

Distribution Services

| Email alert Add to watchlist
jones review results

---

Latest Novartis Kisqali® NATALEE analysis reinforces 25% reduction in risk of recurrence across broad population of patients with early breast cancer; supports regulatory submissions - December 8, 2023
Published: 2023-12-08 (Crawled : 16:00) - biospace.com/
NVSEF | News | $95.11 6.88% 490 |

Health Technology

| -1.82% | O: -1.29% H: 0.4% C: 0.4%
PFE | News 4 | $26.32 0.23% 0.0% 24M |

Health Technology

| -8.28% | O: 0.07% H: 1.1% C: 0.45%
NVS | News | $97.28 2.27% 0.31% 3.7M |

Health Technology

| -1.21% | O: 0.19% H: 0.35% C: 0.2%
kisqali breast risk novartis

---

Active Pharmaceutical Ingredients Market to Surpass $372.4 Billion, Globally, by 2030 at 6.8% CAGR: Coherent Market Insights (CMI)
Published: 2023-12-08 (Crawled : 15:00) - prnewswire.com
ENDPQ | News | $0.0007 -50.0% 1K |

n/a

| 60.0% | O: -20.0% H: 0.0% C: 0.0%
NVSEF | News | $95.11 6.88% 490 |

Health Technology

| -1.82% | O: -1.29% H: 0.4% C: 0.4%
PPCB | $0.0011 -41.86% 5.6M |

Manufacturing

| -88.7% | O: 0.0% H: 2.61% C: -4.35%
PFE | News 4 | $26.32 0.23% 0.0% 24M |

Health Technology

| -8.28% | O: 0.07% H: 1.1% C: 0.45%
NVS | News | $97.28 2.27% 0.31% 3.7M |

Health Technology

| -1.21% | O: 0.19% H: 0.35% C: 0.2%
active market

---

Latest Novartis Kisqali® NATALEE analysis reinforces 25% reduction in risk of recurrence across broad population of patients with early breast cancer; supports regulatory submissions
Published: 2023-12-08 (Crawled : 14:00) - globenewswire.com
NVSEF | News | $95.11 6.88% 490 |

Health Technology

| -1.82% | O: -1.29% H: 0.4% C: 0.4%
PFE | News 4 | $26.32 0.23% 0.0% 24M |

Health Technology

| -8.28% | O: 0.07% H: 1.1% C: 0.45%
NVS | News | $97.28 2.27% 0.31% 3.7M |

Health Technology

| -1.21% | O: 0.19% H: 0.35% C: 0.2%
kisqali breast risk novartis

---

Red Biotechnology Market to Reach $1,513.22 Billion, Globally, by 2030 at 10.7% CAGR: Coherent Market Insights
Published: 2023-12-08 (Crawled : 08:00) - prnewswire.com
ALPMF | News | $9.75 43.47% 200 |

Health Technology

| -21.02% | O: -2.79% H: 0.62% C: 0.62%
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| 2.34% | O: 2.06% H: 0.82% C: 0.82%
NVSEF | News | $95.11 6.88% 490 |

Health Technology

| -1.82% | O: -1.29% H: 0.4% C: 0.4%
ALPMY | News | $9.53 -1.11% 690K |

Manufacturing

| -22.27% | O: -2.2% H: 0.0% C: -0.27%
TAK | News | $13.38 0.15% 0.9% 1.7M |

Health Technology

| -5.11% | O: -0.64% H: 0.5% C: 0.5%
NVO | News | $128.64 2.7% -0.07% 3.7M |

Health Technology

| 29.39% | O: -0.42% H: 0.67% C: 0.25%
NVS | News | $97.28 2.27% 0.31% 3.7M |

Health Technology

| -1.21% | O: 0.19% H: 0.35% C: 0.2%
JNJ | News | $149.56 0.3% 0.0% 9.1M |

Health Technology

| -4.39% | O: -0.18% H: 0.0% C: 0.0%
LLY | News | $745.69 1.96% -0.16% 2M |

Health Technology

| 24.67% | O: 0.43% H: 0.0% C: 0.0%
BMY | $48.99 -0.31% 0.0% 9.1M |

Health Technology

| -2.03% | O: 0.2% H: 0.55% C: 0.1%
ABBV | News | $169.54 0.98% -0.91% 4.1M |

Health Technology

| 13.6% | O: 0.3% H: 0.0% C: 0.0%
SNY | News | $47.69 1.15% 1.13% 1.7M |

Health Technology

| 1.21% | O: 1.07% H: 0.0% C: 0.0%
GILD | $67.03 0.12% 0.12% 5.2M |

Health Technology

| -14.22% | O: 0.08% H: 1.45% C: 1.17%
AMGN | News | $273.69 0.66% 0.65% 2.5M |

Health Technology

| 0.22% | O: -0.05% H: 0.3% C: -0.76%
reach market

---

FDA Approves Bio-Thera Solutions' Avzivi® (bevacizumab-tnjn), a biosimilar referencing Avastin®
Published: 2023-12-07 (Crawled : 00:00) - biospace.com/
NVS | News | $97.28 2.27% 0.31% 3.7M |

Health Technology

| -2.35% | O: -0.97% H: 0.3% C: -0.19%
avzivi fda biosimilar

---

Antibody Therapeutics Market Worth $479.0 Billion | MarketsandMarkets
Published: 2023-12-07 (Crawled : 15:30) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| 0.64% | O: -1.66% H: 0.0% C: 0.0%
NVS | News | $97.28 2.27% 0.31% 3.7M |

Health Technology

| -2.35% | O: -0.97% H: 0.3% C: -0.19%
JNJ | News | $149.56 0.3% 0.0% 9.1M |

Health Technology

| -5.94% | O: -1.61% H: 0.0% C: 0.0%
ABBV | News | $169.54 0.98% -0.91% 4.1M |

Health Technology

| 15.83% | O: 1.97% H: 0.0% C: 0.0%
SNY | News | $47.69 1.15% 1.13% 1.7M |

Health Technology

| 0.01% | O: -1.19% H: 0.0% C: 0.0%
REGN | News | $906.84 0.74% 0.74% 340K |

Health Technology

| 7.71% | O: 0.51% H: 1.22% C: 1.09%
IMNM | $14.64 -4.19% -4.37% 890K |

Health Technology

| 94.9% | O: -0.64% H: 1.67% C: -1.16%
BIIB | $193.18 -0.48% -0.48% 1.4M |

Health Technology

| -17.0% | O: 1.67% H: 0.91% C: 0.57%
antibody therapeutics market

---

Parkinson's Disease Therapeutics Market revenue to hit USD 12.32 Billion by 2033, Says We Market Research
Published: 2023-12-06 (Crawled : 15:30) - prnewswire.com
GLAXF | News | $20.305 -14.18% 630 |

Health Technology

| 14.62% | O: 1.64% H: 0.0% C: -1.33%
NVS | News | $97.28 2.27% 0.31% 3.7M |

Health Technology

| -2.27% | O: 0.52% H: 0.18% C: -0.43%
GSK | News | $41.24 1.6% 0.0% 2.3M |

Health Technology

| 11.73% | O: -0.03% H: 0.28% C: -0.41%
LLY | News | $745.69 1.96% -0.16% 2M |

Health Technology

| 25.47% | O: 0.99% H: 0.0% C: 0.0%
ABBV | News | $169.54 0.98% -0.91% 4.1M |

Health Technology

| 16.13% | O: 0.26% H: 0.0% C: 0.0%
DNLI | $16.11 0.75% 0.74% 1.1M |

Health Technology

| -13.75% | O: 0.05% H: 5.74% C: 3.18%
BIIB | $193.18 -0.48% -0.48% 1.4M |

Health Technology

| -15.45% | O: 0.42% H: 2.37% C: 1.45%
disease parkinson's revenue research therapeutics market

---

Novartis receives FDA approval for Fabhalta® (iptacopan), offering superior hemoglobin improvement in the absence of transfusions as the first oral monotherapy for adults with PNH
Published: 2023-12-06 (Crawled : 00:00) - globenewswire.com
NVS | News | $97.28 2.27% 0.31% 3.7M |

Health Technology

| -2.27% | O: 0.52% H: 0.18% C: -0.43%
fabhalta fda first approval offering novartis

---

Fallopian Tube Cancer Therapeutics Market size to grow by USD 832.01 million from 2023-2028| AbbVie Inc., Amgen Inc., Arrien Pharmaceuticals LLC and more among the key companies in the market - Technavio
Published: 2023-12-05 (Crawled : 23:00) - prnewswire.com
GLAXF | News | $20.305 -14.18% 630 |

Health Technology

| 14.62% | O: 1.64% H: 0.0% C: -1.33%
AZNCF | News | $138.73 -4.19% 3.7K |

Health Technology

| 10.32% | O: 1.51% H: 0.13% C: -1.68%
NVS | News | $97.28 2.27% 0.31% 3.7M |

Health Technology

| -2.27% | O: 0.52% H: 0.18% C: -0.43%
GSK | News | $41.24 1.6% 0.0% 2.3M |

Health Technology

| 11.73% | O: -0.03% H: 0.28% C: -0.41%
BAX | $41.02 1.54% 0.0% 2.6M |

Health Technology

| 12.85% | O: 0.14% H: 0.78% C: 0.22%
ABBV | News | $169.54 0.98% -0.91% 4.1M |

Health Technology

| 16.13% | O: 0.26% H: 0.0% C: 0.0%
AZN | News | $70.85 1.03% 1.02% 5.6M |

Health Technology

| 9.56% | O: 0.73% H: 0.06% C: -1.38%
AMGN | News | $273.69 0.66% 0.65% 2.5M |

Health Technology

| 0.38% | O: 0.2% H: 0.2% C: -0.76%
GOOGL | News S | $158.17 1.21% 1.19% 21M |

Technology Services

| 21.15% | O: 1.97% H: 0.0% C: 0.0%
GOOG | News 4 | $159.82 1.18% 1.17% 16M |

Technology Services

| 21.16% | O: 1.97% H: 0.0% C: 0.0%
ADBE A | $472.955 1.3% 1.28% 2.1M |

Technology Services

| -22.47% | O: 0.97% H: 0.08% C: -2.03%
tube companies abbvie cancer pharmaceuticals therapeutics market

---

Rheumatoid Arthritis Drugs Market to grow by USD 16.04 billion from 2023 to 2028; North America to account for 39% of market growth- Technavio
Published: 2023-12-04 (Crawled : 18:00) - prnewswire.com
ALPMF | News | $9.75 43.47% 200 |

Health Technology

| -17.23% | O: 0.26% H: 0.0% C: 0.0%
GLAXF | News | $20.305 -14.18% 630 |

Health Technology

| 10.33% | O: -2.6% H: 1.1% C: -1.18%
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| -1.28% | O: 0.27% H: 0.12% C: 0.12%
NVSEF | News | $95.11 6.88% 490 |

Health Technology

| -2.9% | O: -1.1% H: 0.0% C: 0.0%
ALPMY | News | $9.53 -1.11% 690K |

Manufacturing

| -21.24% | O: 0.0% H: 0.5% C: 0.17%
NVS | News | $97.28 2.27% 0.31% 3.7M |

Health Technology

| -4.26% | O: -1.86% H: 0.34% C: -0.19%
GSK | News | $41.24 1.6% 0.0% 2.3M |

Health Technology

| 10.81% | O: -1.01% H: 0.39% C: 0.19%
ABBV | News | $169.54 0.98% -0.91% 4.1M |

Health Technology

| 17.09% | O: 0.51% H: 0.68% C: 0.32%
SNY | News | $47.69 1.15% 1.13% 1.7M |

Health Technology

| -1.09% | O: -0.5% H: 0.0% C: 0.0%
GLMD | $0.3641 -0.41% 65K |

Health Technology

| -7.67% | O: 0.03% H: 2.44% C: -1.03%
AMGN | News | $273.69 0.66% 0.65% 2.5M |

Health Technology

| -0.23% | O: -0.25% H: 0.05% C: -0.37%
america market

---

Smart Inhaler Technology Market size to grow by USD 46.37 million from 2022-2027, North America to account for 37% of market growth - Technavio
Published: 2023-12-01 (Crawled : 00:20) - prnewswire.com
NVSEF | News | $95.11 6.88% 490 |

Health Technology

| Email alert Add to watchlist
RMD | $184.22 2.15% 0.0% 1.2M |

Health Technology

| Email alert Add to watchlist
AZN | News | $70.85 1.03% 1.02% 5.6M |

Health Technology

| Email alert Add to watchlist
AZNCF | News | $138.73 -4.19% 3.7K |

Health Technology

| Email alert Add to watchlist
NVS | News | $97.28 2.27% 0.31% 3.7M |

Health Technology

| Email alert Add to watchlist
TEVJF | News | $12.37 -24.22% 380 |

Health Technology

| Email alert Add to watchlist
IFNNF | $32.231 -2.1% 410 |

Electronic Technology

| Email alert Add to watchlist
IFNNY | $32.09 -2.12% 550K |

Manufacturing

| Email alert Add to watchlist
america smart technology growth market

---

Gainers vs Losers

78%

22%

Top 10 Gainers

MTTR | News 4 | $4.6 164.37% 62.17% 28M |

AGBA | $2.94 135.2% 57.48% 66M |

Finance

EDBL | News | $6.46 71.81% 41.8% 2M |

MTC | $2.25 44.23% 30.67% 6M |

Technology Services

OPRT | News | $3.175 41.11% 29.13% 12M |

Finance

SHIM | $3.05 35.56% 26.23% 1.1M |

HKIT | $1.345 31.86% 24.16% 390K |

Technology Services

ABVC | $1.36 30.77% 23.53% 7.4M |

Wholesale Trade

OST | $0.512 28.0% 21.88% 290K |

POET | $1.59 27.2% 21.38% 4.2M |

Manufacturing

---

Your saved searches

---